Viewing Study NCT01839656


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2026-02-25 @ 2:36 AM
Study NCT ID: NCT01839656
Status: COMPLETED
Last Update Posted: 2021-02-17
First Post: 2013-04-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Assess the Efficacy, Safety and Pharmacokinetics of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy (SMA)
Sponsor: Biogen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Spinal Muscular Atrophy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Spinal Muscular Atrophy View
None SMA View
None SMN View
None SMNRx View
None ISIS-SMNRx View
None ISIS 396443 View
None IONIS-SMNRx View
None Spinraza View
None Nusinersen View